| |

Artificial Intelligence Tool Measures Mesothelioma Treatment Response

ByAlex Strauss

artificial intelligence toolScientists at the University of Glasgow in Scotland have developed an artificial intelligence tool that could revolutionize the way doctors plan and monitor mesothelioma treatment. 

The University team collaborated with Scottish firm Canon Medical Research Europe to develop an AI prototype for detecting pleural mesothelioma. Canon Medical specializes in medical imaging software. 

Pleural mesothelioma is a type of lung cancer caused by asbestos exposure. The new artificial intelligence tool is designed to find and measure mesothelioma tumors on CT scans. 

It can be challenging even for cancer experts to detect tiny changes in mesothelioma tumors. But the AI tool can quickly reveal how well or poorly a patient is doing on a treatment like chemotherapy. The sooner doctors know if they need to change tactics, the better the patient’s outcome is likely to be. 

‘Teaching’ the Artificial Intelligence Tool

Malignant pleural mesothelioma is a rare and hard-to-treat cancer that grows on the surface of the lungs. Unlike some tumors that are round and easy to see on imaging scans, mesothelioma tumors are flat and irregularly shaped. 

Their unique growth pattern makes these tumors difficult to detect. It also makes it hard for doctors to spot changes in mesothelioma tumors over time. The artificial intelligence tool was designed to make the process easier, faster, and more accurate. 

For the assessment tool to work, it had to be ‘trained’ by expert clinicians. Researchers showed the artificial intelligence tool 100 CT scans from people with pleural mesothelioma. The scans had the tumors marked so that the computer could ‘learn’ exactly what to look for. 

Researchers then tested the tool to see how well it could do the job without help. When they showed the AI a new set of CT scans, it was able to find and measure the mesothelioma tumors with great precision. 

Computer Assessment and the Future of Mesothelioma Treatment

The artificial intelligence tool developed in Scotland could have far-reaching implications. If larger studies confirm that it works well, it could become a routine part of mesothelioma management. By giving doctors a fast, accurate assessment of changes in tumor volume, it could let them know earlier if they are on the right track. 

But the tool could also have an impact on mesothelioma clinical trials. Clinical trials test potentially life-saving cancer treatments in human patients. They may involve large numbers of patients, all of whom have CT scans that have to be analyzed.

“Accurate tumour volume measurements are much too time-consuming to perform by hand,” explains Keith Goatman, Principal Scientist at Canon Medical. “Automating these measurements will open the way for clinical trials of new treatments, by detecting even small changes in the tumour size.”

Goatman says the artificial intelligence tool is a “strong first step” towards changes in the treatment of mesothelioma and other types of cancer. 

At present, there is no cure for mesothelioma. Many patients die of the disease within a year of diagnosis. Scotland has one of the highest incidences of mesothelioma in the world. 

Source:

“Artificial Intelligence Used to Automate Assessment of Mesothelioma”, University of Glasgow News Release, https://www.gla.ac.uk/news/archiveofnews/2021/april/headline_788451_en.html

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    ByAlex Strauss

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    ByAlex Strauss

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    ByAlex Strauss

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    ByAlex Strauss

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    ByAlex Strauss

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    ByAlex Strauss

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…